New Zealand markets closed

Prime Medicine, Inc. (PRME)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.14-0.19 (-3.56%)
At close: 04:00PM EDT
5.14 0.00 (0.00%)
After hours: 05:42PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-204,497
-198,133
-121,821
-165,367
-3,410
Depreciation & amortisation
4,916
4,653
2,224
568
43
Deferred income taxes
57
-279
-964
-624
1,867
Stock-based compensation
17,438
13,910
6,459
1,746
391
Change in working capital
-18,848
2,647
-35,401
31,176
164
Accounts payable
3,764
9,140
2,458
1,185
250
Other working capital
-200,607
-174,136
-147,922
-38,232
-6,183
Other non-cash items
13,305
12,788
9,790
97,313
6,268
Net cash provided by operating activities
-191,558
-165,412
-131,827
-34,082
-5,544
Cash flows from investing activities
Investments in property, plant and equipment
-9,049
-8,724
-16,095
-4,150
-639
Purchases of investments
-166,493
-104,951
-123,336
-81,980
0
Sales/maturities of investments
170,056
132,556
93,000
13,000
0
Other investing activities
-
-170
-665
-496
-423
Net cash used for investing activities
-5,656
18,711
-47,096
-73,626
-1,062
Cash flows from financing activities
Common stock issued
132,055
0
185,317
0
0
Other financing activities
-
-
-4,042
-1,086
-20
Net cash used provided by (used for) financing activities
157,914
655
181,494
269,278
34,934
Net change in cash
-39,300
-146,046
2,571
161,570
28,328
Cash at beginning of period
146,958
201,116
198,545
36,975
8,647
Cash at end of period
107,658
55,070
201,116
198,545
36,975
Free cash flow
Operating cash flow
-191,558
-165,412
-131,827
-34,082
-5,544
Capital expenditure
-9,049
-8,724
-16,095
-4,150
-639
Free cash flow
-200,607
-174,136
-147,922
-38,232
-6,183